The development of antibiotic resistance in anaerobic bacteria has a tremendous impact on the selection of antimicrobial agents for empirical therapy. Susceptibility studies have documented the emergence of antimicrobial resistance and indicate distinct differences in resistance patterns related to individual hospitals, geographic regions, and antibiotic-prescribing regimens. Resistance to /3-lactam drugs, clindamycin, tetracyclines, and 5-nitroimidazoles (metronidazole) has been observed. The prime mechanism for resistance to f3-lactam agents is the production of /3-lactamases. Resistance to clindamycin is mediated by modification of the ribosome. Tetracycline resistance is mediated by both tetracycline efflux and ribosomal protection. 5-Nitroimidazole resistance appears to be caused by a combination of decreased antibiotic uptake and decreased nitroreductase activity. The level of chloramphenicol susceptibility remains quite high, whereas uniform resistance to aminoglycosides and quinolones is observed. Understanding the mechanisms of resistance is critical for both informed selection of antimicrobial therapy and the design of new antimicrobial agents.
The development of antibiotic resistance in anaerobic bacteria has a tremendous impact on the selection of antimicrobial agents for empirical therapy. Susceptibility studies have documented the emergence of antimicrobial resistance and indicate distinct differences in resistance patterns related to individual hospitals, geographic regions, and antibiotic-prescribing regimens. Resistance to /3-lactam drugs, clindamycin, tetracyclines, and 5-nitroimidazoles (metronidazole) has been observed. The prime mechanism for resistance to f3-lactam agents is the production of /3-lactamases. Resistance to clindamycin is mediated by modification of the ribosome. Tetracycline resistance is mediated by both tetracycline efflux and ribosomal protection. 5-Nitroimidazole resistance appears to be caused by a combination of decreased antibiotic uptake and decreased nitroreductase activity. The level of chloramphenicol susceptibility remains quite high, whereas uniform resistance to aminoglycosides and quinolones is observed. Understanding the mechanisms of resistance is critical for both informed selection of antimicrobial therapy and the design of new antimicrobial agents.
Anaerobic bacteria are an important class of human and animal pathogens. Less is often known about anaerobic bacteria than most aerobic or facultative bacteria, but their participation in human health and well-being should not be undervalued. Although clinical laboratories may not always test for these organisms, their susceptibility patterns vary among the different groups, both with respect to organism and with respect to different classes of antimicrobial agents. Thus, it is important to appreciate the variations in resistances and to relate these variations to mechanisms of resistance.
Of the anaerobic bacteria, Bacteroides species are among the most important clinically for two reasons. First, they are the microorganisms most often isolated from patients with suppurative anaerobic infections. Second, they are the anaerobic bacteria with the broadest spectrum of recognized resistances to antimicrobial agents. As such, Bacteroides species have been instrumental in the study of resistance and its transfer among anaerobic bacteria.
Consequently, more is known about antimicrobial resistance in Bacteroides than in any other anaerobic bacteria. For these reasons, the major emphasis of this article will be on the mechanisms of antibiotic resistance in Bacteroides, as an update to our recent review on the mechanisms of resistance in Bacteroides [1] .
Susceptibility Patterns Among Anaerobes
Susceptibility studies are conducted in many countries as an attempt to monitor the development of resistance in specific organisms. A summary of data from worldwide studies that identified the appearance of resistance or an increase in frequency of resistance to different classes of antimicrobial agents is provided in table 1. The agents included were 0-lactam drugs, clindamycin, metronidazole, and chloramphenicol, antimicrobials that have been used extensively to treat anaerobic infections.
Penicillins, including the ureidopenicillin piperacillin, are 0-lactam agents that members of the Bacteroides fragilis group are resistant to. However, the addition of a 0-lactamase inhibitor often allows a labile penicillin to regain its original activity. Cefoxitin, a cephalosporin formerly highly active against anaerobes, is exhibiting decreased potency in many of the recent surveys (table 1) . Imipenem remains the most potent /3-lactam agent. It is notable that Australia is the one country in which MICs of the 0-lactam agents are consistently lower than those in the United States for non fragilis Bacteroides isolates.
Clindamycin and metronidazole are both quite active against the B. fragilis group, although a frequency of resistance to clindamycin of up to 25% has been reported in localized areas such as southern Europe and Japan [6, 12, 15] . Susceptibility patterns for other anaerobes including fusobacteria, clostridia, and propionibacteria are quite different as the penicillins have retained potent activity. A few strains of Clostridium perfringens have been reported to be metronidazole-resistant [15] . It is also notable that resistance to metronidazole is seen in propionibacteria, while other agents are quite active. NOTE. Amp = ampicillin; CA = clavulanic acid fixed at 2 gg/mL; Cfox = cefoxitin; Chl = chloramphenicol; Cm = clindamycin; Imi = imipenem; Mtz = metronidazole; ND = no data provided; Pen = penicillin G; Pip = piperacillin; Sulb = sulbactam; Taz = tazobactam; Tic = ticarcillin. * Fixed ratio of 2:1. Ratio of 8:1.
effective against these isolates. Cefoxitin has lost its role as a 0-lactam agent with guaranteed potency, but it still is used when strains are susceptible after testing. Generally, narrow-spectrum penicillins and cephalosporins should not be considered efficacious agents against Bacteroides species, but for some isolates expanded-spectrum cephalosporins will be effective.
Resistance to the /3-lactam agents can be caused by any of the three major resistance determinants: an altered killing target with poor binding for the 0-lactam agent (e.g., low-affinity penicillin-binding proteins [PBPs] ), decreased permeability, and the presence of an inactivating enzyme (i.e., a 0-lactamase with the ability to hydrolyze the 0-lactam drug to form an inactive entity). The most common mechanism at this time is inactivation by one of the various groups of (3-lactamases found in the anaerobic bacteria. A lengthy discussion of resistance to the 0-lactam agents has been published recently [1] , and only an update of more current information will be included in the following section.
0-Lactamases. Production of (3-lactamases by anaerobes is a common occurrence; as many as 97%-100% of Bacteroides isolates in the United States [16, 17] and 76% of such isolates in Great Britain [18] produce 0-lactamases. Sixty-five percent of non fragilis Bacteroides species produce 0-lactamases [19] . Most enzymes from Bacteroides are chromosomally mediated and are produced constitutively. They include enzymes with serine at the active site as well as enzymes known to be metalloenzymes requiring an active site with Zn' for hydrolysis of the 0-lactam agent to occur.
Production of f3-lactamases by other anaerobic bacteria has been less well studied, but enzyme production by Clostridium butyricum [20, 21] , Clostridium clostridioforme [22] , Clostridium ramosum [23] , Prevotella, Porphyromonas [24] , and Fusobacterium [19, 24] has been reported. Although only isolated strains of Clostridium appear to produce 0-lactamases, Prevotella, Porphyromonas, and fusobacteria produce these enzymes more frequently; Jacobs et al. [17] and Appelbaum and coworkers [19] reported that 71%, 30%, and 41% of these strains, respectively, were /3-lactamase producers. Enzymes produced by clostridia are generally inducible. The exception is the 0-lactamase produced by C. ramosum that Matthew [23] NOTE. Relative hydrolysis rates are based on a standard of 100. Cephaloridine is the standard for comparison among all agents except for the enzyme group 2a, for which penicillin G is the standard. Amp = ampicillin; CA = clavulanic acid; Cfox = cefoxitin; Clor = cephaloridine; Clox = cloxacillin; Ctax = cefotaxime; Cthn = cephalothin; IC 50 = inhibitory concentration of 50%; Imi = imipenem; ND = no data provided; Pen G = benzylpenicillin; pI = isoelectric point; Sulb = sulbactam; ? = not enough information for a firm assignment; + = presence of hydrolyzing activity but no quantitative data provided; -= absence of hydrolyzing activity but no quantitative data provided.
* Enzymes classified according to Bush et al. [25] . Molecular class as defined by Ambler [40] . Only those enzymes for which a sequence has been determined are listed with a class designation. Inactivation detected microbiologically. Relative Vmax < 1 compared with that of Clor. Cfox inactivation decreased in the presence of CA.
reported; this 0-lactamase was the common plasmid-mediated TEM-1 enzyme. Functional classifications [25] of the fi-lactamases from anaerobic bacteria are given in table 2. Most enzymes produced by the anaerobes have acidic isoelectric points. Many enzymes from the B. fragilis group are group 2e cephalosporinases that can be inhibited by the classical /3-lactamase inhibitors (clavulanic acid, sulbactam, and tazobactam), thus explaining the susceptibilities of many Bacteroides strains to the combinations of a 0-lactam agent with a /3-lactamase inhibitor. These enzymes account for most /3-lactamases produced by Bacteroides strains. Several of these enzymes have now been sequenced and have been confirmed to belong to the molecular class A serine cephalosporinases [33] [34] [35] , which have smaller molecular sizes than the inducible group 1 (molecular class C) cephalosporinases from gram-negative bacteria. Only one strain of Bacteroides intermedius has been reported to produce a group 1 cephalosporinase that is not inhibited by clavulanic acid [26] .
An unusual set of cefoxitin-hydrolyzing enzymes from several members of the B. fragilis group has been reported [1] (table 2). These enzymes have not been completely characterized but may eventually be assigned to group 2e. Although exact rates of hydrolysis were not determined for the enzymes, HPLC revealed that the group 2e (class A) CfxA ,8-lactamase from Bacteroides vulgatus degraded cefoxitin slowly in overnight cultures, but hydrolysis could not be detected in standard spectrophotometric assays [35] . Because the /3-lactamase-producing organisms are clinically resistant to cefoxitin, it is possible that slow enzymatic hydrolysis is coupled with decreased permeability.
Fusobacteria and clostridia produce penicillinases rather than cephalosporinases. These organisms produce at least three groups of enzymes, although not all substrates have been tested with all enzymes. Penicillinases from fusobacteria and C. butyricum have been reported to be inhibited by clavulanic acid, whereas the penicillinase from C. clostridioforme was not inhibited by any of the three commercially available f3-lactamase inhibitors [22] . This behavior is characteristic of enzymes belonging to molecular class D 0-lactamases, the group 2d cloxacillin-hydrolyzing enzymes.
Production of metallo-/3-lactamases is perhaps the most disturbing development over the past 10 years in terms of resistance to ,8-lactam agents in B. fragilis. These enzymes, which require Zn ++ at the active site, readily hydrolyze all 41-lactam agents except the monobactam agents [38] , which have no antibacterial activity against Bacteroides. They also cannot be inhibited by the available 0-lactamase inhibitors. Although these enzymes are usually chromosomally mediated, a plasmidmediated metallo-/3-lactamase has been reported in Japan [39] . The appearance of this set of enzymes has put the clinical use of carbapenems, previously the 0-lactam agents most active against these organisms, into jeopardy.
Permeability. Decreased permeability has often been associated with increased /3-lactamase production as a cause of resistance to antimicrobial agents in gram-negative bacteria. Several studies have indicated that permeability factors can vary among strains of B. fragilis [36, 37, 41] . In certain B. fragilis strains, resistance was also correlated with both reduced permeability and expression of enzymatic activity [41] . In another study, cefoxitin resistance was correlated with a decrease in outer-membrane permeability and the loss of an outer-membrane protein with a molecular size of 49-50 kD [42] .
PBPs. Binding to PBPs is the critical factor that determines whether a 13-lactam agent will be effective as an antimicrobial agent. PBPs function in the terminal stage of cell wall synthesis and are essential for growth of bacteria. When a 41-lactam agent is able to compete successfully for the active site of an essential PBP, cell death will occur. In Bacteroides strains, three to five PBPs can exist: a PBP 1 complex with one to three different enzymes, PBP 2, and PBP 3. These PBPs are assumed to correspond to the essential high-molecular-weight PBPs found in aerobic gram-negative bacteria. There may be other lowmolecular-weight PBPs, but the number of these proteins varies among strains, thereby suggesting that they are probably not critical for growth [43] .
Most 0-lactam agents bind well to PBP 2, with good binding to the PBP 1 complex. Monobactam agents such as aztreonam seem to have very poor affinity for the B. fragilis PBPs, thus accounting for their lack of antimicrobial activity against these organisms [44] . Although resistance to cephalosporins can be attributed to 0-lactamase production in most Bacteroides strains, decreased affinity for PBP 3 was also demonstrated in B. fragilis G-232 from Japan [45] . Cefoxitin resistance in selected Bacteroides strains has also been attributed to decreased binding to PBP 2 or the PBP 1 complex [42, 46] .
Clindamycin
In general, the rate of clindamycin resistance in Bacteroides species continues to remain relatively low [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] 47] , and this drug remains effective as treatment of infections due to Bacteroides. However, the rate of resistance varies dramatically between different institutions and countries. Resistance rates can range from almost 0 to >20% [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] 47] . Therefore, surveillance of resistance is essential in assessing the utility of clindamycin as a therapeutic agent at a given facility.
The three classic mechanisms of antibiotic resistance (inactivation of the drug, altered permeability, and altered target site [i.e., the ribosome]) have all been reported as mechanisms of clindamycin resistance [48, 49] . Macrolide/lincosamide/streptogramin B (MLS) resistance is a representative of the latter mechanism and is the most common mechanism of clindamycin resistance in Bacteroides species. DNA and protein sequence analysis and biochemical evidence indicate that MLS resistance in Bacteroides occurs by a mechanism similar to that of clindamycin resistance in staphylococci [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] .
In staphylococci, resistance is mediated by methylation of the 23S rRNA at one of two adenine residues [50] . This methylation prevents effective binding of clindamycin to the ribosomes and renders them resistant to the drug's inhibitory effects. Supporting this same mechanism of resistance in Bacteroides species is the findings of Reig et al. [52] and Jimenez-Diaz et al. [56] ; these researchers demonstrated that ribosomes isolated from a B. vulgatus strain with clindamycin resistance, which was induced with either clindamycin or erythromycin, showed decreased susceptibility to inactivation by clindamycin compared with ribosomes isolated from a clindamycin-susceptible strain or a strain with clindamycin resistance that was not induced. This observation indicates that resistance to clindamycin is at the level of the ribosome and most likely occurs via methylation of the rRNA, although methylation has not yet been directly demonstrated.
Three different, but very closely related (>95% homologous), MLS resistance genes have been cloned from various Bacteroides strains. All three genes lie within a transposon or on a conjugal element: ermF is encoded on Tn4351, ermFS is encoded on Tn4551, and ermFU is encoded on a B. vulgatus conjugal element [53] [54] [55] . In addition to being highly homologous with each other, their encoded proteins have sequence identities that are highly similar to those of the MLS resistance genes from gram-positive organisms [53] [54] [55] . Most clindamycin-resistant Bacteroides harbor an erm gene related to one of the three genes mentioned above. However, not all clindamycin-resistant Bacteroides contain DNA sequences that crosshybridize with the ermF gene [57] [58] [59] , thus indicating that another unrelated MLS resistance gene or another mechanism of resistance is also present in Bacteroides species.
Conjugal transfer of clindamycin resistance, first reported in 1979 by researchers at three laboratories [60] [61] [62] , was shown to be plasmid-mediated. Many of these plasmids are self-transmissible and range in size from 14.6 kilobases (kb) (pBFTM10) to 41 kb (pIP411 and pBF4) [61] to -82 kb (pBI136) [63] . Studies with pBFTM10 and pBF4 have demonstrated that the clindamycin resistance genes harbored by these plasmids are carried on transposons Tn4400 and Tn4351, respectively [64, 65] . Resistance to clindamycin has also been documented to be chromosomally encoded. In several cases, chromosomal resistance to clindamycin has been linked with resistance to tetracycline; in fact, the clindamycin resistance gene lies within the tetracycline resistance transfer element (see below) [65] [66] [67] . Clindamycin resistance can be inducible as well as constitutive.
Tetracycline
Resistance to tetracycline is nearly universal in Bacteroides, with the rate of resistance exceeding 80%-90% at most institutions [10, 68] . In fact, most surveys of antimicrobial resistance in Bacteroides no longer include data on susceptibility to tetracycline. Because of the high rate of resistance, tetracycline is no longer an effective first-line antibiotic for the empirical treatment of bacteroides infections as it was through the 1960s. Tetracyclines can no longer be used as treatment of bacteroides infections without susceptibility testing.
Modification or protection of the target site is the only documented mechanism of tetracycline resistance in Bacteroides species. The tetQ gene encodes a protein that is able to render the ribosomal protein synthesis machinery resistant to the protein synthesis inhibitory effects of the tetracycline class of antibiotics [59, 69, 70] . Several Bacteroides tetQ genes have been cloned, and their DNA sequences have been determined [69, 70] . TetQ is the most distantly related tetracycline resistance protein that functions via ribosomal protection; it is -40% homologous with TetM and TetO proteins and has been proposed to represent a new class of ribosomal protection proteins [69, 70] .
DNA cross-hybridization studies indicate that a tetQ or tetQrelated gene is present in most tetracycline-resistant Bacteroides isolates [59] . However, the identification of tetracyclineresistant isolates that do not contain tetQ DNA sequences indicates that another mechanism (such as tetracycline efflux) or another class of ribosomal protection proteins also contributes to tetracycline resistance. In fact, a tetM-related determinant has been identified in some tetracycline-resistant isolates of Bacteroides ureolyticus [71] .
Two tetracycline resistance genes have recently been identified in C. perfringens. The tetA(P) and tetB(P) genes form an operon encoding two unrelated proteins that bestow tetracycline resistance mediated by two different mechanisms [72] . The tetA(P) gene product is a tetracycline efflux pump, while tetB(P) encodes a protein conferring tetracycline resistance at the level of the ribosome [72] . The TetB(P) protein has sequences that are significantly similar to those of other TetMlike proteins that specify a ribosomal protection mechanism of tetracycline resistance [72] .
Two additional genes related to tetracycline resistance have been identified in Bacteroides species. The tetX gene product is able to inactivate tetracycline by oxidation of the molecule [73, 74] . The TetX protein, however, is active only under aerobic conditions and has not been demonstrated to be functional in Bacteroides [73, 75] . A gene encoding a protein that is able to actively produce tetracycline efflux has been identified in Bacteroides [76, 77] . However, this efflux pump is not able to bestow tetracycline resistance on Escherichia coli and therefore is not believed to contribute to tetracycline resistance in Bacteroides [77] .
Tetracycline resistance mediated by the tetQ gene is both inducible [69, 78] and transferable [60, 79] . This transfer of tetracycline resistance was first reported by Privitera et al. in 1979 [60, 79] . The frequency of transfer of tetracycline resistance is generally very low unless the cells are preexposed to tetracycline [80] [81] [82] . The mechanism of transfer is by conjugation mediated by the tetracycline resistance transfer element itself [78, 83, 84] . The regulation of transfer is controlled by a classical prokaryotic two-component regulatory system [78, 84] . The two regulatory genes, rteA and rteB, are located in the tetQ operon downstream from the tetQ gene [84] . Their expression is greatly enhanced in the presence of tetracycline, thus explaining the increased transfer following exposure to tetracycline.
The rteA gene encodes RteA, the cytoplasmic membrane protein component of the system [84] . The rteB gene encodes RteB, the regulatory response protein that may elicit its effect through an interaction with a a 54 -like protein [84] . RteB plays an essential role in the transfer and mobilization of the tetracycline resistance transfer element. A third gene, rteC, has also been demonstrated to be involved in self-transfer of tetracycline resistance [78] . Its gene product, RteC, follows RteB in the regulation cascade. The precise role of RteC in the regulation of the transfer process has not been elucidated.
In addition to regulating the movement of the tetracycline resistance transfer element, RteA and RteB are also involved in the regulation of transfer of unlinked chromosomal elements termed nonreplicating Bacteroides units (NBUs) [59, [82] [83] [84] [85] . Although most NBUs do not carry an identifiable phenotype, a cefoxitin-hydrolyzing /3-lactamase gene (cfxA [35] ) has been shown to reside on an NBU [86] . Transfer of the cefoxitinhydrolyzing 0-lactamase is enhanced by pretreatment with tetracycline [86, 87] .
These tetracycline resistance transfer elements reside in the chromosome. [59, 80, 81] . The elements are large, with estimated sizes ranging from 70 to 80 kbp [83] , and often also harbor other resistance genes (e.g., ermF) [66] . Except for their large size, the tetracycline resistance transfer elements in Bacteroides are similar to the conjugal transposon Tn91 6 in Enterococcus faecalis that was described by Franke and Clewell [88] .
5-Nitroimidazoles (Metronidazole)
Metronidazole, the first 5-nitroimidazole to be used clinically, was introduced in 1960, but it was not until 1978 that Ingham et al. [89] reported the first clinical isolate of B. fragilis that was metronidazole-resistant after long-term therapy. Subsequent reports have included descriptions of metronidazoleresistant Bacteroides isolates from patients not treated with metronidazole [90] [91] [92] . One explanation for these resistant isolates is that metronidazole was inactivated by another bacterium. It has been reported that E. faecalis is able to inactivate metronidazole and protect B. fragilis from its antimicrobial effects in mixed culture [93] . Nevertheless, rates of metronidazole resistance remain extremely low, generally <1% [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] 47] , and this drug remains highly effective as treatment of bacteroides infections.
The 5-nitroimidazoles, including metronidazole, tinidazole, and ornidazole, must be reduced to form the active antibacterial agent [94] . This reduction is stable only under anaerobic conditions as it is quickly reversed in the presence of oxygen [94, 95] . Resistance to metronidazole is often associated with reduced nitroreductase activity and decreased uptake of the drug [94, 95] . Both of these conditions occur simultaneously [94, 95] . Because entry of 5-nitroimidazoles into the cell depends on the rate of reduction of the nitro group, a decrease in the reducing environment within the cell will result in reduced nitroreductase activity as well as reduced uptake of the drug.
Decreased pyruvate:ferredoxin oxidoreductase activity in combination with a compensatory increase in the lactate dehydrogenase activity results in a decrease in the reducing state of the cell [94, 95] . The ease with which this change in enzyme activities can be accomplished by the cell is unknown. However, the phenotype in a metronidazole-resistant isolate has been identified [96] .
Two genes, nimA and nimB, that are able to confer moderateto high-level metronidazole resistance have been identified [97] . Screening of a group of metronidazole-resistant B. fragilis isolates indicated that all of the isolates harbored DNA sequences that hybridized with either an nimA or nimB DNA probe, while none of the metronidazole-susceptible isolates screened contained DNA sequences that cross-hybridized with an nimA or nimB DNA probe [98] . The DNA sequence of the nimA and nimB genes is -73% similar, and presumably they represent two classes of genes that confer resistance via the same mechanism [97] . The mechanism of resistance has not been elucidated, but drug uptake studies indicate that active efflux or reduced drug penetration was not involved [97] .
The nimA and nimB genes have been localized both to the chromosome and to various plasmids [99, 100] . The plasmids harboring the nimA or nimB gene have not been demonstrated to be self-transmissible, but these plasmids can be mobilized by other conjugal elements or acquired by transformation [101] . It is interesting that the transcriptional start information for both the nimA and nimB genes that have been sequenced is provided by an insertion sequence (IS) element integrated 12-14 bases upstream from the protein-coding region. For the nimA gene, this element is 151168 [97] . A very closely related IS element provides the transcriptional start information for the nimB gene [97] . 151168 is nearly identical to an IS element, 151186, that has been identified to provide transcriptional initiation signals for the Bacteroides metallo-O-lactamase gene [97, 102] .
Chloramphenicol
Most antimicrobial susceptibility surveys have not reported resistance to chloramphenicol [2, 3, 8, 10] . This lack of resistance may be due in part to the infrequent use of chloramphenicol as treatment of bacterial infections. However, failure of chloramphenicol treatment for a patient with meningitis and ventriculitis caused by B. fragilis was reported [103] .
Two different classes of chloramphenicol resistance genes have been identified in Bacteroides species. Both classes of genes confer resistance via drug inactivation, either by nitroreduction at the p-nitro group on the benzene ring [104] or by acetylation [105, 106] . In the latter case, the resistance was transferable and was associated with the transfer of a 39.5-kb plasmid, pRYC3373 [106] .
Aminoglycosides
Aminoglycoside resistance is universal in anaerobic bacteria. This common resistance is not the result of decreased sensitivity of the target to the drug, as both streptomycin and gentamicin are able to bind to and inhibit protein synthesis occurring on B. fragilis and C. perfringens ribosomes in a cell-free system [107] . Drug inactivation also does not account for this resistance, as no drug inactivation has been seen with cell extracts of either B. fragilis or C. perfringens [107] . Rather, resistance is the result of failure of the drug to reach its target.
Uptake of aminoglycosides is a two-step process involving an energy-independent phase and an energy-dependent phase. An oxygen-or nitrogen-dependent electron transport system provides the energy necessary for the energy-driven phase of drug uptake. Strictly anaerobic bacteria lack this electron transport system and therefore do not import aminoglycosides [108] . Supporting this statement is the observation that aminoglycosides do not accumulate within B. fragilis or C. perfringens [107] . It can, therefore, be surmised that these compounds are not active against Bacteroides and clostridia simply because they do not reach their target site.
Quinolones
Although highly effective against many aerobic bacteria, the quinolones and fluoroquinolones generally show poor activity against most anaerobic bacteria. MICs of quinolones for most Bacteroides isolates are 2 //g/mL [109] [110] [111] [112] [113] [114] . Different sur- veys report MICs of various quinolones that range from 0.8 tg/mL [115] to >400 ,ug/ml [116, 117] . Studies determining if the low rate of susceptibility is a consequence of poor drug penetrability, low affinity of the drugs for the target, DNA gyrase, or another mechanism have not been performed. However, decreased cell permeability has been suggested to be responsible for the observed resistance to both cefoxitin and norfloxacin in a number of clinical isolates of Bacteroides [116] .
One reservation to the use of quinolones as treatment of anaerobic infections is the observation that the quinolones are not bactericidal but are bacteriostatic under anaerobic conditions [118, 119] . However, there is the hope that despite a poor history, some of the newer quinolones (such as WIN57273, tosufloxacin, and CI960) may prove to be therapeutically effective as treatment of bacteroides infections [120] .
Discussion
Rates of resistance in the anaerobes, particularly Bacteroides species, have not increased dramatically since we last reviewed this subject in 1992 [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] . The mechanisms of antimicrobial resistance in aerobic and anaerobic bacteria (table 3) continue to remain the same. However, some features of antimicrobial resistance and expression of the resistance determinants in Bacteroides differ from those seen in many other bacterial species.
Many of the resistance determinants identified in Bacteroides reside on the chromosome. Plasmids harboring multiple antibiotic resistance genes that readily move from one isolate to another are not a major feature of Bacteroides. The tetracycline resistance gene lies on a conjugal element that is most often integrated within the chromosome [80, 83, 84] . With the exception of the metallo-/3-lactamase gene in Japan, which can be located on a plasmid [39] , this gene is found to be chromosomally encoded in the other strains that have been studied [37, 83] . The nimA and nimB genes have been found on the chromosome and on plasmids, although not self-mobilizing plasmids [99, 101] . The MLS genes have been identified to reside on transposons and conjugal elements often integrated within the chromosome [55, 66] .
The chromosomal location of many of these resistance genes may tend to slow the spread of resistance. However, it should not be overlooked that some of the resistance markers (e.g., the tetracycline resistance tetQ gene) are located on self-mobilizing elements whose transfer is enhanced by pretreatment with the very drug for which the markers encode resistance [80, 83] . This phenomenon may in large part be responsible for the rapid dissemination and high incidence of tetracycline resistance in Bacteroides species.
It is also interesting that many of the Bacteroides resistance genes are transcribed from transcriptional initiation signals provided by an IS element integrated within the promoter rather than from their natural promoters (table 4) . This circumstance is the case for the ermF and ermFS genes (whose transcriptional initiation signals are provided by 154351 [53, 54] ), the metallo-/3-lactamase gene ccrA (also known as cfiA; at least two different IS elements have been identified that provide the transcriptional initiation signals [102, 121] ), and the nimA and nimB genes [97] . In general, when expression is provided by a promoter encoded on an IS element, the antimicrobial resistance is constitutive not inducible, which tends to be the case for most resistance genes. -This finding leads to the speculation as to why these genes are not transcribed from their natural promoters: were the genes acquired from another bacterium whose transcriptional initiation signals are not optimal for expression in Bacteroides, were they acquired without the regulatory genes needed to permit optimal expression, or is the inducer for their expression a compound other than the one for which they impart resistance? The answers to these questions are unknown. It is clear however, that IS element-driven transcriptional gene activation impacts on the spread and rate of antimicrobial resistance in
Bacteroides.
It has been demonstrated that the metallo-O-lactamase gene is present in >1%-3% of Bacteroides isolates, yet only a fraction of these isolates are resistant to imipenem [39, 41, 122, 123] . The metallo-/3-lactamase-positive imipenem-susceptible isolates can easily convert to being imipenem-resistant in a [102, 121] nimA and nimB genes 1S1168 [97] * Macrolide/lincosamide/streptogramin B resistance.
5-Nitroimidazole resistance.
Downloaded from https://academic.oup.com/cid/article-abstract/24/Supplement_1/S110/283494 by guest on 07 December 2018 single step by the insertion of an IS element into the promoter [102, 122] . The IS element provides the transcriptional initiation information, and expression of the imipenem-hydrolyzing metallo-O-lactamase becomes constitutive. It is interesting that among Bacteroides species, the IS elements that have been identified to provide transcriptional initiation signals to antibiotic resistance genes are found almost exclusively in the subpopulation of isolates that harbor the resistance genes [97, 102] . Thus, the cells are armed with the IS elements needed to activate expression of the resistance gene(s) that they harbor. The rate of antibiotic resistance in anaerobic bacteria will undoubtedly continue to increase. The existence of populations of Bacteroides harboring silent antibiotic resistance genes that can be activated by the simple insertion of an IS element within the promoter bodes an ominous forecast for the rate at which resistance may emerge given selection pressure.
The increasing threat of antibiotic resistance necessitates the development of new antimicrobial agents. Elucidation of the molecular mechanism(s) of resistance is critical to the design of effective new drugs. Strains harboring defined resistance(s) can be used to screen potential new compounds for their effectiveness against preexisting resistances. Knowledge of the active site of a given resistance protein will permit the modeling of novel chemical structures and modification of known active compounds to create new agents with activity against resistant organisms. It is hoped that such efforts will yield new antimicrobial agents that will be effective as treatment of infections caused by resistant bacteria, both anaerobic and aerobic.
